Pharma & Bio
Technology
Will the 20-Year Quest for a Domestic Foot-and-Mouth Disease Vaccine Finally Be Fulfilled? OptiPharm Enters Final Stage
The domestic livestock industry is on the verge of achieving the localization of foot-and-mouth disease (FMD) vaccines, a product it has relied on imports for decades. With #OptiPharm recently receivi…
Technology
CoreLineSoft Goes Beyond Simple Image Analysis, Opening a Blue Ocean in 'Digital Biomarkers'
#CoreLineSoft is reaching a turning point where it will expand beyond simple image interpretation assistance into the digital biomarker business. This is because CoreLineSoft has secured AI-based quan…
Lifestyle
"From Diagnosis to Treatment"... FutureChem: What Is the Strategy to Complete the Puzzle with Therapeutic Radiopharmaceuticals?
#FutureChem has decided on a final round of fundraising ahead of its full-scale revenue generation and has secured a cash cow, allowing it to accelerate the development of FC705, a radiopharmaceutical…
Technology
Curocell’s ‘Limkato,’ the First Domestically Developed CAR-T Therapy, Sets Sights on Japan
#Curocell, the first Korean company to successfully commercialize the chimeric antigen receptor T-cell (CAR-T) therapy Limkato, is now setting its sights on the Japanese market as its next strategic t…
Lifestyle
NextBio’s ‘Nexpire F’ Demonstrates Potential for Endless Evolution... Proven by a Series of Clinical Successes
#NextBioMedical is reshaping the medical device market landscape, centered on its knee osteoarthritis treatment, NexSphere F. This is because NexSphere F, which started as a treatment for knee osteoar…
Lifestyle
Dasan Pharmaceutical Accelerates CDMO Push in Japan... "Full-Scale Supply of Flagship Pellet Product Begins"
Dasan Pharmaceutical has successfully completed an on-site inspection by Japan’s Pharmaceutical and Medical Devices Agency (PMDA), accelerating its efforts to penetrate the local market and expand its…
Lifestyle
Vivozon Pharma and Lunit Rally on Commercialization and Nvidia Tailwinds [K-Bio Pulse]
Following a broad rally across Korea’s pharmaceutical and biotech sector the previous day, trading on June 10 shifted toward stock-specific momentum. Vivozon Pharm surged nearly 10% on expectations fo…
Lifestyle
Bibozon Pharma and Lunit Rise in Tandem... Expectations for Commercialization and NVIDIA-Driven Expansion [Bio Spotlight]
Following a broad rally across the pharmaceutical and biotech sectors the previous day, the market on the 10th saw a differentiated trend centered on stocks with individual momentum. Vibozon Pharmaceu…
Technology
Countdown to the '270 Trillion Won Patent Cliff'… K-Bio Targets Big Pharma’s Territory Through Speed and Niche Markets
The largest-ever patent cliff is looming over the global pharmaceutical and biotech markets. This is because the expiration dates for the exclusive rights to global mega-blockbuster drugs—which previo…
Lifestyle
The Era of 2 Million Foreign Patients: "They Start by Looking for Shrink in Korea"... Why You Should Keep an Eye on Classis
With the dawn of an era featuring 2 million foreign patients, #Classis’ growth strategy and global scalability are drawing renewed attention. This is because a virtuous cycle is forming where medical …